Status:
UNKNOWN
SARS-CoV-2 Disguise Study
Lead Sponsor:
Meshalkin Research Institute of Pathology of Circulation
Conditions:
Sars-CoV2
Eligibility:
All Genders
18+ years
Brief Summary
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is a pandemic disease with worldwide spreading. Limited data are existed regarding SARS-CoV-2 positive carriers among asymptomati...
Eligibility Criteria
Inclusion
- Asymptomatic medical employees of E. Meshalkin National Medical Research Center of the Ministry of Health of the Russian Federation
- Filled questionnaire before SARS-CoV-2 testing
- Nasopharyngeal and oropharyngeal testing for SARS-CoV-2
- Signed informed consent
Exclusion
- Unwilling to participate
Key Trial Info
Start Date :
May 7 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
November 30 2020
Estimated Enrollment :
900 Patients enrolled
Trial Details
Trial ID
NCT04395794
Start Date
May 7 2020
End Date
November 30 2020
Last Update
May 20 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Meshalkin National Medical Research Center
Novosibirsk, Russia, 630055